Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

300.00p
   
  • Change Today:
      13.00p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 325,249
  • Market Cap: £300.00m
  • RiskGrade: 125

Latest ShareCast News

Oxford Biomedica confident as it moves away from vaccine era

By Josh White

Date: Monday 29 Apr 2024

(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.

OXB Regulatory News

Total Voting Rights 01-May-2024 07:00 RNS
2023 Annual Report and Accounts 30-Apr-2024 17:00 RNS
Prelim Results for Y/E 2023 - REPLACEMENT 29-Apr-2024 09:38 RNS
Preliminary results for the year ended 31 Dec 2023 29-Apr-2024 07:00 RNS
Total Voting Rights 02-Apr-2024 07:00 RNS

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 300.00p
Change Today 13.00p
% Change 4.53 %
52 Week High 470.00
52 Week Low 166.80
Volume 325,249
Shares Issued 100.00m
Market Cap £300.00m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.48% below the market average25.48% below the market average25.48% below the market average25.48% below the market average25.48% below the market average
13.73% above the sector average13.73% above the sector average13.73% above the sector average13.73% above the sector average13.73% above the sector average
Price Trend
19.06% below the market average19.06% below the market average19.06% below the market average19.06% below the market average19.06% below the market average
41.82% above the sector average41.82% above the sector average41.82% above the sector average41.82% above the sector average41.82% above the sector average
Income Not Available
Growth
52.27% below the market average52.27% below the market average52.27% below the market average52.27% below the market average52.27% below the market average
54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 6
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 02-May-2024

Time Volume / Share Price
16:39 35,562 @ 298.33p
16:35 50,193 @ 300.00p
16:35 255 @ 300.00p
16:35 1,428 @ 300.00p
16:35 378 @ 300.00p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page